참여증명서 발급문의하기사이트맵

ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.

전체 2310건의 자료가 검색되었습니다.

Excel Download

코로나19(COVID19) 임상시험 현황
No. Status Study Title Conditions Interventions Phase Sponsor/Collaborators Funder Type Number Enrolled Sex Age Locations
2107 Terminated A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects Covid19 Drug: GT0918
Drug: Standard of care
Drug: Matching placebo
Phase 3 Suzhou Kintor Pharmaceutical Inc, INDUSTRY 139 All 18 Years Alternative Research Associates LLC., Hialeah, Florida, United States
Sparrow Hospital, Lansing, Michigan, United States
Hannibal Clinic (HC), Hannibal, Missouri, United States
Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico, United States
Saint Lawrence Health System, New York, New York, United States
Ascension St. John Medical Center, Tulsa, Oklahoma, United States
Medical City Fort Worth, Fort Worth, Texas, United States
PRX Research, Mesquite, Texas, United States
Shanghai Public Health Clinical Center, Jinshan, Shanghai, China
The Third People's Hospital of Shenzhen, Longgang, Shenzhen, China
Beijing Ditan Hospital Capital Medical University, Beijing, China
Davao Doctors Hospital, Davao City, Davao, Philippines
St. Paul's Hospital, Iloilo City, Iloilo, Philippines
Philippine General Hospital, Malina, Metro Malina, Philippines
Mary Johnston Hospital (MJH), Manila, Metro Manila, Philippines
Quirino Memorial Medical Center, Quezon City, Metro Manila, Philippines
Lung Center of the Philippines, Quezon City, Philippines
Johese Clinical Research: Unitas, Centurion, South Africa
Drs Sarvan and Moodley, Durban, South Africa
TASK Eden, George, South Africa
Johese Clinical Research ZAH, Pretoria, South Africa
Dr JM Engelbrecht Practice, Vergelegen Mediclinic, Somerset, South Africa
Clinical Projects Research, Worcester, South Africa
Communal Noncommercial Profit, Dnipro, Dnipro Oblast, Ukraine
Ivano-Frankivsk Clinical Regional Infectious Diseases Hospital, Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine
Kharkiv city clinical hospital #13, Kharkiv, Kharkiv Oblast, Ukraine
CNE of Kharkov RC Reg Cl Infectious Hospital, Kharkiv, Kharkiv Oblast, Ukraine
City Clinical infectious Hospital, Odesa, Odesa Oblast, Ukraine
Poltava Regional Clinical, Poltava, Poltava Oblast, Ukraine
CCH #1 Vinnytsia M.I.Pyrogov NMU Ch of Infectious Diseases, Vinnytsia, Vinnytsia Oblast, Ukraine
2106 Completed A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia COVID-19 Pneumonia Drug: Remdesivir
Drug: Tocilizumab
Drug: Placebo
Phase 3 Hoffmann-La Roche, Gilead Sciences INDUSTRY 649 All 12 Years Valleywise Health Medical Center, Phoenix, Arizona, United States
eStudySite - Chula Vista - PPDS, Chula Vista, California, United States
Hoag Hospital Irvine, Irvine, California, United States
Providence St Johns Health Center, Santa Monica, California, United States
Yale University School of Medicine; HIV Clinical Trials Program, New Haven, Connecticut, United States
Medstar Georgetown University Hospital, Washington, District of Columbia, United States
Holy Cross Hospital Inc, Fort Lauderdale, Florida, United States
Larkin Community Hospital Palm Springs Campus (Hialeah), Hialeah, Florida, United States
University of Miami Miller School of Medicine; Clinical Reseach Building, Miami, Florida, United States
Larkin Community Hospital, South Miami, Florida, United States
St Luke's Health System; Rheumatology Research, Boise, Idaho, United States
Advocate Christ Medical Center, Oak Lawn, Illinois, United States
Ochsner Clinic Foundation, New Orleans, Louisiana, United States
University of Maryland, Baltimore, Maryland, United States
Boston Medical Center, Boston, Massachusetts, United States
Baystate Medical Center, Springfield, Massachusetts, United States
Henry Ford Medical Center, Novi, Michigan, United States
St. Michael'S Medical Center, Newark, New Jersey, United States
San Juan Oncology Associates, Farmington, New Mexico, United States
Wyckoff Heights Medical Center, Staten Island, New York, United States
Novant Health Clinical Research, Charlotte, North Carolina, United States
OhioHealth Research Institute, Columbus, Ohio, United States
Providence Saint Vincent's Medical Center, Portland, Oregon, United States
Lehigh Valley Hospital, Allentown, Pennsylvania, United States
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Medical University of South Carolina, Charleston, South Carolina, United States
The Liver Institute at Methodist Dallas, Arlington, Texas, United States
Baylor Scott and White Medical Center - College Station, College Station, Texas, United States
Baylor University Medical Center, Dallas, Texas, United States
Baylor St. Luke's Medical Center, Houston, Texas, United States
Ben Taub General Hospital - HCHD, Houston, Texas, United States
Houston Methodist Hospital, Houston, Texas, United States
Baylor Scott & White Medical Center - Irving, Irving, Texas, United States
Baylor Scott & White Hospital - Plano, Plano, Texas, United States
Baylor Scott & White Health, Temple, Texas, United States
Intermountain LDS Hospital, Salt Lake City, Utah, United States
The Providence Regional Medical Center Everett, Everett, Washington, United States
West Virginia University Hospital, Morgantown, West Virginia, United States
Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, MG, Brazil
Hospital Nossa Senhora das Gracas; Setor de Pesquisa em Neurologia, Curitiba, PR, Brazil
Instituto de Pesquisa Clinica Evandro Chagas - IPEC FIOCRUZ, Rio de Janeiro, RJ, Brazil
CEMEC - Centro Multidisciplinar de Estudos Clinicos, Sao Bernardo Do Campo, SP, Brazil
Hospital de Base de Sao Jose do Rio Preto, Sao Jose do Rio Preto, SP, Brazil
Instituto de Infectologia Emilio Ribas, Sao Paulo, SP, Brazil
Instituto do Coracao - HCFMUSP, Sao Paulo, SP, Brazil
Medsi Clinic, Moscow, Adygeja, Russian Federation
O.M. Filatov City Clinical Hospital #15; Department of Surgery, Moskva, Moskovskaja Oblast, Russian Federation
City Pokrovskaya Hospital, Sankt-peterburg, Sankt Petersburg, Russian Federation
City Clinical Hospital # 52, Moscow, Russian Federation
Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain
Hospital Universitario Principe de Asturias; Medicina Interna - Servicio de Enfermedades Infecciosas, Alcala de Henares, Madrid, Spain
Hospital Universitario HM Torrelodones, Torrelodones, Madrid, Spain
Hospital General Universitario de Guadalajara, Guadalajara, Spain
Hospital Universitario Fundacion Jimenez Diaz., Madrid, Spain
2105 Active, not recruiting A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years SARS-CoV-2 Infection Biological: SCTV01E
Biological: Placebo
Phase 3 Sinocelltech Ltd. INDUSTRY 10000 All 18 Years Guizhou center for disease control and prevention, Guiyang, Guizhou, China
2104 Completed A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia COVID-19 Pneumonia Drug: Placebo
Drug: Tocilizumab
Phase 3 Genentech, Inc. INDUSTRY 377 All 18 Years Banner - University Medical Center Phoenix; In-Patient Pharmacy, Phoenix, Arizona, United States
Univ of AZ Coll of Med, Tucson, Arizona, United States
El Centro Regional Medical Center, El Centro, California, United States
eStudySite, La Mesa, California, United States
Highland Hospital Oakland, Oakland, California, United States
St. Joseph'S Hospital, Orange, California, United States
San Leandro Hospital; Inpatient Pharmacy, San Leandro, California, United States
Larkin Community Hospital Palm Springs Campus (Hialeah), Hialeah, Florida, United States
Miami Veterans Administration Healthcare System - NAVREF, Miami, Florida, United States
University of Miami Pulmonary, Miami, Florida, United States
Larkin Community Hospital, South Miami, Florida, United States
St. Lukes Boise Medical Center, Boise, Idaho, United States
Ochsner Clinic, New Orleans, Louisiana, United States
Holy Cross Germantown Hospital, Germantown, Maryland, United States
Holy Cross Hospital, Silver Spring, Maryland, United States
Henry Ford Health System, Detroit, Michigan, United States
St. Joseph'S Regional Medical Center, Paterson, New Jersey, United States
San Juan Oncology Associates, Farmington, New Mexico, United States
St. Barnabas Hospital, Bronx, New York, United States
SUNY Downstate Medical Center., Brooklyn, New York, United States
Elmhurst Hospital Center, Elmhurst, New York, United States
Flushing Hospital, Flushing, New York, United States
Jamaica Hospital Medical Center, Jamaica, New York, United States
Harlem Hospital, New York, New York, United States
Canton-Potsdam Hospital, Potsdam, New York, United States
Novant Health Presbyterian Medical Center (Presbyterian Hospital), Charlotte, North Carolina, United States
Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States
Temple University Hospital, Philadelphia, Pennsylvania, United States
Valley Baptist Medical Center, Harlingen, Texas, United States
Michael E Debakey VA Medical Center, Houston, Texas, United States
McAllen Medical Center, McAllen, Texas, United States
Sentara Medical Group, Virginia Beach, Virginia, United States
Hospital E Maternidade Celso Pierro PUCCAMP, Campinas, SP, Brazil
Centro Multidisciplinar de Estudos Clinicos CEMEC FMABC, Sao Bernardo Do Campo, SP, Brazil
BR Trials - Pesquisa Clinica, Sao Paulo, SP, Brazil
Aga Khan University Hospital, Nairobi, Kenya
Hospital General de Culiacan, Culiacan, Mexico
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico, Mexico
Hospital Militar Central, Jesus Maria, Peru
Hospital Nacional Sergio E. Bernales, Lima, Peru
Hospital Nacional Cayetano Heredia, Lima, Peru
Hospital Nacional Hipolito; Unanue, Lima, Peru
Hospital Maria Auxiliadora, Lima, Peru
George Provincial Hospital, George, South Africa
2103 Completed A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19 Severe COVID-19 Drug: VB-201 + Standard of care
Drug: Standard of care
Phase 2 Vascular Biogenics Ltd. operating as VBL Therapeutics INDUSTRY 5 All 18 Years ~ 80 Years Chaim Sheba Medical Center, Ramat Gan, Israel
2102 Completed A Study to Evaluate the Efficacy of PanCytoVir™ for the Treatment of Non-Hospitalized Patients With COVID-19 Infection COVID-19 Drug: PanCytoVir™ (probenecid)
Drug: Placebo
Phase 2 TrippBio, Inc. INDUSTRY 75 All 18 Years PCMCs PGI Yashwantrao Chavan Memorial Hospital, Pune, India
2101 Withdrawn A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection Covid19 Drug: Xlear Nasal Spray
Drug: Placebo
Phase 3 Larkin Community Hospital OTHER 0 All 18 Years ~ 90 Years Larkin Community Hospital, Miami, Florida, United States